Research Center for Behavioral Disorders and Substance Abuse, Hamadan University of Medical Sciences, Hamadan, Iran.
University of Basel, Psychiatric Clinics (UPK), Center for Affective, Stress and Sleep Disorders (ZASS), Basel, Switzerland.
Psychiatry Res. 2018 Aug;266:40-46. doi: 10.1016/j.psychres.2018.05.031. Epub 2018 May 12.
Suicide and suicide attempts are dramatic events for both the individuals concerned and for their social environments. Efforts have been made to identify reliable biological predictors of suicide and suicide attempts. In the present study, we focused on one potential marker, cholecystokinin (CCK), among first time suicide attempters. A total of 25 suicide attempters (mean age: 30 years; 80% females) and 23 healthy controls were enrolled in the present cross-sectional study. Experts rated participants' symptoms of depression (Hamilton Depression Rating Scale; HDRS). Blood levels of CCK levels were assessed. Suicide attempters had CCK levels 22.67 times higher and HDRS scores 14.33 higher than healthy controls. CCK levels were only weakly associated with HDRS scores. CCK appears to be a fairly reliable biomarker for suicide attempts. However, CCK levels were not associated with depression scores, making it difficult to match biological markers to depressive behaviour.
自杀和自杀未遂是涉及个人及其社会环境的戏剧性事件。人们一直在努力寻找自杀和自杀未遂的可靠生物学预测指标。在本研究中,我们关注了一个潜在的标志物,即胆囊收缩素(CCK),在首次自杀未遂者中。本横断面研究共纳入 25 名自杀未遂者(平均年龄:30 岁;80%为女性)和 23 名健康对照者。专家对参与者的抑郁症状进行了评分(汉密尔顿抑郁评定量表;HDRS)。评估了 CCK 水平的血液水平。自杀未遂者的 CCK 水平比健康对照组高 22.67 倍,HDRS 评分高 14.33 分。CCK 水平与 HDRS 评分仅呈弱相关。CCK 似乎是自杀未遂的一个相当可靠的生物标志物。然而,CCK 水平与抑郁评分无关,这使得将生物标志物与抑郁行为相匹配变得困难。